Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: A 10/66 Population-Based Study

English version České info

Background:
Rapid demographic ageing is a growing public health issue in many low- and middle-income countries (LAMICs). Mild cognitive impairment (MCI) is a construct frequently used to define groups of people who may be at risk of developing dementia, crucial for targeting preventative interventions. However, little is known about the prevalence or impact of MCI in LAMIC settings.

Methods and Findings:
Data were analysed from cross-sectional surveys established by the 10/66 Dementia Research Group and carried out in Cuba, Dominican Republic, Peru, Mexico, Venezuela, Puerto Rico, China, and India on 15,376 individuals aged 65+ without dementia. Standardised assessments of mental and physical health, and cognitive function were carried out including informant interviews. An algorithm was developed to define Mayo Clinic amnestic MCI (aMCI). Disability (12-item World Health Organization disability assessment schedule [WHODAS]) and informant-reported neuropsychiatric symptoms (neuropsychiatric inventory [NPI-Q]) were measured. After adjustment, aMCI was associated with disability, anxiety, apathy, and irritability (but not depression); between-country heterogeneity in these associations was only significant for disability. The crude prevalence of aMCI ranged from 0.8% in China to 4.3% in India. Country differences changed little (range 0.6%–4.6%) after standardization for age, gender, and education level. In pooled estimates, aMCI was modestly associated with male gender and fewer assets but was not associated with age or education. There was no significant between-country variation in these demographic associations.

Conclusions:
An algorithm-derived diagnosis of aMCI showed few sociodemographic associations but was consistently associated with higher disability and neuropsychiatric symptoms in addition to showing substantial variation in prevalence across LAMIC populations. Longitudinal data are needed to confirm findings—in particular, to investigate the predictive validity of aMCI in these settings and risk/protective factors for progression to dementia; however, the large number affected has important implications in these rapidly ageing settings.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: A 10/66 Population-Based Study. PLoS Med 9(2): e32767. doi:10.1371/journal.pmed.1001170
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001170

Souhrn

Zdroje

1. UN, Affairs DoEaS 2006 World population prospects: 2006 revision. New York Population Division, UN Secretariat

2. MathersCDLoncarD 2006 Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 e442 doi:10.1371/journal.pmed.0030442

3. FerriCPPrinceMBrayneCBrodatyHFratiglioniL 2005 Global prevalence of dementia: a Delphi consensus study. Lancet 366 2112 2117

4. PrinceMJacksonJCAlbaneseESousaRMFerriCP 2009 World Alzheimer Report. London King's College London

5. Llibre RodriguezJJFerriCPAcostaDGuerraMHuangY 2008 Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet 372 464 474

6. CummingsJL 2004 Treatment of Alzheimer's disease: current and future therapeutic approaches. Rev Neurol Dis 1 60 69

7. KaduszkiewiczHZimmermannTBeck-BornholdtHPvan den BusscheH 2005 Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 331 321 327

8. WilcockGK 2004 Primary prevention of dementia. Psychiatry 3 35 36

9. PetersenRCSmithGEWaringSCIvnikRJTangalosEG 1999 Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 303 308

10. PetersenRCStevensJCGanguliMTangalosEGCummingsJL 2001 Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 1133 1142

11. PurserJLFillenbaumGGPieperCFWallaceRB 2005 Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort. J Am Geriatr Soc 53 1966 1972

12. HunderfundALRobertsROSlusserTCLeibsonCLGedaYE 2006 Mortality in amnestic mild cognitive impairment: a prospective community study. Neurology 67 1764 1768

13. PalmerKBackmanLWinbladBFratiglioniL 2003 Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ 326 245

14. PanzaFCapursoCD'IntronoAColaciccoAMCapursoA 2007 Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia. Neurobiol Aging 28: 1631-1632; discussion 1633-1634

15. StephanBCMatthewsFEMcKeithIGBondJBrayneC 2007 Early cognitive change in the general population: how do different definitions work? J Am Geriatr Soc 55 1534 1540

16. ArnaizEAlmkvistOIvnikRJTangalosEGWahlundLO 2004 Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry 75 1275 1280

17. XuGMeyerJSHuangYChenGChowdhuryM 2004 Cross-cultural comparison of mild cognitive impairment between China and USA. Curr Alzheimer Res 1 55 61

18. ApostolovaLGCummingsJL 2008 Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 25 115 126

19. PalmerKBackmanLWinbladBFratiglioniL 2008 Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 16 603 611

20. PetersenRCRobertsROKnopmanDSGedaYEChaRH 2010 Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 75 889 897

21. BusseABischkopfJRiedel-HellerSGAngermeyerMC 2003 Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med 33 1029 1038

22. DlugajMWeimarCWegeNVerdePEGerwigM 2010 Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort. Dement Geriatr Cogn Disord 30 362 373

23. GamaldoAAAllaireJCSimsRCWhitfieldKE 2010 Assessing mild cognitive impairment among older African Americans. Int J Geriatr Psychiatry 25 748 755

24. GanguliMChangCCSnitzBESaxtonJAVanderbiltJ 2010 Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project. Am J Geriatr Psychiatry 18 674 683

25. GanguliMDodgeHHShenCDeKoskyST 2004 Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63 115 121

26. HanninenTHallikainenMTuomainenSVanhanenMSoininenH 2002 Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 106 148 154

27. JungwirthSWeissgramSZehetmayerSTraglKHFischerP 2005 VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Int J Geriatr Psychiatry 20 452 458

28. KochanNASlavinMJBrodatyHCrawfordJDTrollorJN 2010 Effect of different impairment criteria on prevalence of “objective” mild cognitive impairment in a community sample. Am J Geriatr Psychiatry 18 711 722

29. LiJWangYJZhangMXuZQGaoCY 2011 Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 76 1485 1491

30. LopezOLJagustWJDeKoskySTBeckerJTFitzpatrickA 2003 Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 60 1385 1389

31. ManlyJJBell-McGintySTangMXSchupfNSternY 2005 Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 62 1739 1746

32. MeguroKIshiiHYamaguchiSIshizakiJSatoM 2004 Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project. Alzheimer Dis Assoc Disord 18 3 10

33. RitchieKArteroSTouchonJ 2001 Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 56 37 42

34. DickersonBCSperlingRAHymanBTAlbertMSBlackerD 2007 clinical prediction of alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 64 1443 1450

35. RappSRLegaultCHendersonVWBrunnerRLMasakiK 2010 Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study. Alzheimer Dis Assoc Disord 24 248 255

36. YaffeKMiddletonLELuiLYSpiraAPStoneK 2011 Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol 68 631 636

37. DasSKBosePBiswasADuttABanerjeeTK 2007 An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology 68 2019 2026

38. LeeLKShaharSChinAVMohd YusoffNARajabN 2011 Prevalence of gender disparities and predictors affecting the occurrence of mild cognitive impairment (MCI). Arch Gerontol Geriatr 54 185 191

39. KimKWParkJHKimMHKimMDKimBJ 2011 A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis 23 281 291

40. PrinceMFerriCPAcostaDAlbaneseEArizagaR 2007 The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health 7 165

41. PrinceMAcostaDChiuHScazufcaMVargheseM 2003 Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361 909 917

42. CopelandJRDeweyMEGriffiths-JonesHM 1986 A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16 89 99

43. CopelandJRPrinceMWilsonKCDeweyMEPayneJ 2002 The Geriatric Mental State Examination in the 21st century. Int J Geriatr Psychiatry 17 729 732

44. HallKSHendrieHCBrittainHMNortonJAJr.RodgersDD 1993 The Development of a dementia screening interview in two distinct languages. International Journal of Methods in Psychiatric Research 3 1 28

45. WelshKAButtersNMohsRCBeeklyDEdlandS 1994 The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44 609 614

46. UstunTBKostanjsekNChatterjiS Rehm J Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva World Health Organization In press

47. RehmJÜstünTBSaxenaSNelsonCBChatterjiS 1999 On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Meth Psych Res 8 110 122

48. SousaRMDeweyMEAcostaDJotheeswaranATCastro-CostaE 2010 Measuring disability across cultures–the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries. The 10/66 Dementia Research Group population-based survey. Int J Methods Psychiatr Res 19 1 17

49. KauferDICummingsJLKetchelPSmithVMacMillanA 2000 Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12 233 239

50. GurujeOUnverzargtFWOsuntokunBOHendrieHCBaiyewuO 1995 The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample. West Afr J Med 14 29 33

51. AlbertMSDekoskySTDicksonDDuboisBFeldmanHH 2011 The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 270 279

52. LarrieuSMLetenneurLPOrgogozoJMMFabrigouleCPAmievaHP 2002 Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59 1594 1599

53. PalmerKWang H-X, BackmanLWinbladBFratiglioniL 2002 Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiat 159 436 442

54. GrahamJERockwoodKBeattieBLEastwoodRGauthierS 1997 Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349 1793

55. GauthierSTouchonJ 2005 Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 62 1164 1166 discussion 1167

56. PetersenRCMorrisJC 2005 Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62 1160 1163 discussion 1167

57. RaschettiRAlbaneseEVanacoreNMagginiM 2007 Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med 4 e338 doi:10.1371/journal.pmed.0040338

58. WhitehousePJMoodyHR 2006 Mild cognitive impairment: A ‘hardening of the categories’? Dementia 5 11 25

59. GanguliMChandraVGilbyJERatcliffGSharmaSD 1996 Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int Psychogeriatr 8 507 524

60. KimJMStewartRPrinceMShinISYoonJS 2003 Diagnosing dementia in a developing nation: an evaluation of the GMS-AGECAT algorithm in an older Korean population. Int J Geriatr Psychiatry 18 331 336

61. PrinceMJde RodriguezJLNoriegaLLopezAAcostaD 2008 The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health 8 219

62. STATA 2007 Stata Statistical Software: Release 10. LPS College Station (Texas) StataCorp. LP 2007

63. SousaRMFerriCPAcostaDAlbaneseEGuerraM 2009 Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet 374 1821 1830

64. LumleyTKronmalRMaS 2006 Relative risk regression in medical research: models, contrasts, estimators, and algorithms. Technical report 293, UW Biostatistics Working Paper Series. Available: http://www.bepress.com/uwbiostat/paper293. Accessed 8 January 2012.

65. G Zou 2004 A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 702 706

66. HigginsJPThompsonSG 2002 Quantifying heterogeneity in a meta-analysis. Stat Med 21 1539 1558

67. RitchieKTouchonJ 2000 Mild cognitive impairment: conceptual basis and current nosological status. Lancet 355 225 228

68. MatthewsFEStephanBCBondJMcKeithIBrayneC 2007 Operationalization of mild cognitive impairment: a graphical approach. PLoS Med 4 1615 doi:10.1371/journal.pmed.0040304

69. TognoniGCeravoloRNucciaroneBBianchiFDell'AgnelloG 2005 From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand 112 65 71

70. BusseABischkopfJRiedel-HellerSGAngermeyerMC 2003 Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand 108 71 81

71. FratiglioniLWinbladBvon StraussE 2007 Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Physiol Behav 92 98 104

72. LyketsosCGLopezOJonesBFitzpatrickALBreitnerJ 2002 Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288 1475 1483

73. GedaYERobertsROKnopmanDSPetersenRCChristiansonTJ 2008 Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 65 1193 1198

74. PalmerKBergerAKMonasteroRWinbladBBackmanL 2007 Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68 1596 1602

75. MuangpaisanWIntalapapornSAssantachaiP 2008 Neuropsychiatric symptoms in the community-based patients with mild cognitive impairment and the influence of demographic factors. Int J Geriatr Psychiatry 23 699 703